Skip to main content

Advertisement

Fig. 5 | BMC Musculoskeletal Disorders

Fig. 5

From: In vitro chondrogenic potency of surplus chondrocytes from autologous transplantation procedures does not predict short-term clinical outcomes

Fig. 5

Comparison of selected molecular biomarkers between clinical groups. a Surface protein expression by flow cytometry from donors of clinical success (n = 3, upper panels) and failure (n = 3; low panels). Red peak represents the isotype control, and blue, orange and green peak represent the tested cell surface marker for each donor. Average median fluorescence intensity (MFI) +/− standard error demonstrated differences in surface marker expression between two groups. b Analysis of selected genes of interest by qPCR revealed their relative expression in the success (n = 8) and failure (n = 5) groups. Plotted values represent each donor, and the error bar represents standard deviation. Significance level, p (*) < 0.05 and (**) < 0.005

Back to article page